Metamizol Normon (Metamizole Sodium Monohydrate)

Metamizole sodium works by inhibiting cyclooxygenase‑mediated prostaglandin production and by modulating central pain pathways. This dual action reduces inflammation‑driven pain signals and helps reset the body’s temperature‑regulating center, providing analgesic and antipyretic effects.

The appropriate dose of Metamizol Normon is determined by the prescribing clinician based on the patient’s condition, severity of symptoms, age, weight, and renal or hepatic function. Dosage instructions are provided on the prescription label and should be followed exactly.

Safety data for metamizole sodium in pregnancy and lactation are limited. It should be used only if the potential benefit justifies the possible risk to the fetus or infant, and only under direct medical supervision.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with traditional NSAIDs such as ibuprofen, metamizole offers potent analgesia and antipyresis with a lower risk of gastrointestinal ulceration but carries a unique risk of agranulocytosis. Choice of therapy depends on individual patient risk factors and clinical judgment.

Metamizol Normon tablets should be stored at ambient temperature, below 25 °C, in the original container to protect from moisture and light. Keep out of reach of children and do not use after the expiry date printed on the package.

The medication is supplied as oral tablets. Patients should swallow the tablet whole with a full glass of water, unless otherwise directed by a healthcare professional. It is taken by mouth as prescribed, typically with or without food.

The most serious adverse events include agranulocytosis, which can lead to severe infections, and rare but life‑threatening allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome. Immediate medical attention is required if signs of infection, rash, or breathing difficulty develop.

Metamizol Normon should be avoided in individuals with known hypersensitivity to metamizole or other pyrazolones, in patients with existing blood dyscrasias, severe liver or kidney impairment, and in pregnant or breastfeeding women unless the benefit outweighs the risk.